Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 26;7(5):e0147.
doi: 10.1097/HC9.0000000000000147. eCollection 2023 May 1.

Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey

Affiliations

Wide variation in pre-procedural blood product transfusion practices in cirrhosis: a national multidisciplinary survey

Natasha Janko et al. Hepatol Commun. .

Abstract

Background and aims: Recent guidelines recognize the limitations of standard coagulation tests in predicting bleeding and guiding pre-procedural blood component prophylaxis in cirrhosis. It is unclear whether these recommendations are reflected in clinical practice. We performed a nationwide survey to investigate pre-procedural transfusion practices and opinions of key health care stakeholders involved in managing cirrhosis.

Methods: We designed a 36-item multiple-choice questionnaire to investigate the international normalized ratio and platelet cutoffs utilized to guide pre-procedural transfusion of fresh frozen plasma and platelets in patients with cirrhosis undergoing a range of low and high-risk invasive procedures. Eighty medical colleagues from all mainland States involved in managing patients with cirrhosis were invited by email to participate.

Results: Overall, 48 specialists across Australia completed the questionnaire: 21 gastroenterologists, 22 radiologists, and 5 hepatobiliary surgeons. 50% of respondents reported that their main workplace did not have written guidelines relating to pre-procedural blood component prophylaxis in patients with cirrhosis. There was marked variation in routine prophylactic transfusion practices across institutions for the different procedures and international normalized ratio and platelet cutoffs. This variation was present both within and between specialty groups and held for both low and high-risk procedures. For scenarios where the platelet count was ≤ 50 × 109/L, 61% of respondents stated that prophylactic platelet transfusions would be given before low-risk and 62% before high-risk procedures at their center. For scenarios where the international normalized ratio was ≥2, 46% of respondents stated that prophylactic fresh frozen plasma would be routinely given before low-risk procedures and 74% before high-risk procedures.

Conclusion: Our survey reveals significant heterogeneity of pre-procedural prophylactic transfusion practices in patients with cirrhosis and discrepancies between guidelines and clinical practice.

PubMed Disclaimer

Conflict of interest statement

Amanda Nicoll advises and is on the speakers’ bureau for Eisai. She advises Roche and AstraZeneca and is on the speakers’ bureau for Ipsen. Jacob George advises and is on the speakers’ bureau for Pfizer. He advises AbbVie, AstraZeneca, and Gilead. He is on the speakers’ bureau for Roche. The remaining authors have no conflicts to report.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
Percentage of proceduralists who give platelet transfusion according to platelet cutoff for low and high-risk procedures (Current practice).
FIGURE 2
FIGURE 2
Percentage of proceduralists who give prophylactic fresh frozen plasma transfusion according to INR cutoff for low and high-risk procedures (Current practice).

Similar articles

Cited by

References

    1. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413–1425. - PubMed
    1. Janko N, Majeed A, Commins I, Kemp W, Roberts SK. Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis. Eur J Gastroenterol Hepatol. 2022;34(2):192–199. - PubMed
    1. Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, et al. . Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. Eur J Intern Med. 2017;38:79–82. - PubMed
    1. Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, et al. . Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: results from the PRO-LIVER Study. Am J Gastroenterol. 2018;113:368–375. - PubMed
    1. Kovalic AJ, Majeed CN, Samji NS, Thuluvath PJ, Satapathy SK. Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis. Alimentary Pharmacol Ther. 2020;52:1298–1310. - PubMed